Detalhe da pesquisa
1.
Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
Gastroenterology
; 157(3): 807-822, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31194980
2.
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Lancet Oncol
; 19(7): 940-952, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29875066
3.
Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
Hepatology
; 65(4): 1352-1368, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27981611
4.
Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.
Histopathology
; 70(3): 492-498, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27391928
5.
Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE-PVE: a comparative study.
Surg Endosc
; 31(5): 2340-2349, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27655376
6.
Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.
Liver Int
; 35(10): 2203-17, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26123841
7.
Early and resectable HCC: Definition and validation of a subgroup of patients who could avoid liver transplantation.
J Surg Oncol
; 111(8): 1007-15, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918872
8.
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Lancet Oncol
; 15(8): 819-28, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852116
9.
Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies.
Invest New Drugs
; 32(5): 1028-35, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748335
10.
[Metabolic syndrome, non alcoholic hepatic steatopathy and hepatocellular carcinoma: so dangerous liaisons]. / Syndrome métabolique, stéatopathie hépatique non alcoolique (NASH) et carcinome hépatocellulaire: des liaisons bien dangereuses....
Bull Acad Natl Med
; 198(9): 1653-63; discussion 1663-4, 2014 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-27356367
11.
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study.
J Hepatol
; 58(1): 81-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22989572
12.
Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.
J Hepatol
; 57(1): 108-15, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22414764
13.
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
Eur J Cancer
; 167: 1-12, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364421
14.
Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
J Hepatol
; 55(6): 1187-94, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703195
15.
The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study.
Eur Radiol
; 21(2): 281-90, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20683597
16.
Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Lancet Gastroenterol Hepatol
; 6(8): 649-658, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34087115
17.
Preoperative risk score for prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma: Report of a collaborative, international-based, external validation study.
Eur J Surg Oncol
; 46(4 Pt A): 560-571, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718919
18.
Evidence-based integration of selective internal radiation therapy into the management of cholangiocarcinoma.
Future Oncol
; 10(15 Suppl): 89-92, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25478776
19.
Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features.
Cancer Lett
; 450: 155-168, 2019 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849481
20.
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.
Aliment Pharmacol Ther
; 49(3): 308-320, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30569507